| Supportive Oncology Care at Home for Patients With Pancreatic Cancer Receiving Preoperative FOLFIRINOX (NCT03798769) | Massachusetts General Hospital | 2019-01-31 |
| 9-ING-41 in Patients With Advanced Cancers (NCT03678883) | Actuate Therapeutics Inc. | 2019-01-04 |
| Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. (NCT03992664) | Cyprus University of Technology | 2019-01-01 |
| Evaluation and Comparison of the Growth Rate of Pancreatic Cancer Patient-derived Organoids (NCT03990675) | Technical University of Munich | 2018-12-01 |
| A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) (NCT02905578) | University of Iowa | 2018-11-28 |
| Study of ADCT-301 in Patients With Selected Advanced Solid Tumors (NCT03621982) | ADC Therapeutics S.A. | 2018-11-09 |
| Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors (NCT03755739) | Second Affiliated Hospital of Guangzhou Medical University | 2018-11-01 |
| PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma (NCT04099134) | University of Ulm | 2018-10-10 |
| Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy (NCT04466189) | National Cancer Center, Korea | 2018-09-21 |
| CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC) (NCT03682744) | Sorrento Therapeutics, Inc. | 2018-09-13 |
| Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial (NCT03400072) | Centre Hospitalier Universitaire de Besancon | 2018-08-03 |
| Study Comparing Pancreatic EUS-FNB With the 20-gauge Procore® and the 22-gauge Acquire® Needles (NCT03567863) | Société Française d'Endoscopie Digestive | 2018-06-24 |
| Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma (NCT03484299) | University of Louisville | 2018-05-30 |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas (NCT03451773) | National Cancer Institute (NCI) | 2018-05-17 |
| Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer (NCT03513198) | University of Medicine and Pharmacy Craiova | 2018-05-01 |
| Bethanechol Prior to Pancreatic Surgery (NCT03572283) | Columbia University | 2018-04-08 |
| The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer (NCT03637569) | Samsung Medical Center | 2018-04-01 |
| High-dose Vitamin D3 in Pancreas Cancer (NCT03472833) | Medical University of Graz | 2018-04-01 |
| PTFE Stents for Treatment of Malignant Biliary Strictures (NCT03763214) | Johannes Vermehren | 2018-03-01 |
| Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples (NCT04246710) | Catholic University of the Sacred Heart | 2018-01-28 |
| A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126) | Asana BioSciences | 2018-01-19 |
| Early Recovery Outcomes After Standardized Fast-track Whipples Procedure (NCT03566056) | Eske Kvanner Aasvang | 2018-01-18 |
| Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy (NCT03122106) | Washington University School of Medicine | 2018-01-05 |
| Celiac Plexus Radio-Surgery for Pain Management (NCT03323489) | Dr. Yaacov Lawrence | 2018-01-01 |
| Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model (NCT03934606) | Abramson Cancer Center at Penn Medicine | 2018-01-01 |
| Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies (NCT03199586) | Novita Pharmaceuticals, Inc. | 2017-12-21 |
| Pancreatic Cancer & Surgical Resection (NCT05170802) | Methodist Health System | 2017-12-20 |
| Effects of Prehabilitation and Early Mobilization for Patients Undergoing Pancreas Surgery. (NCT03466593) | Göteborg University | 2017-12-18 |
| Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) (NCT03410030) | HonorHealth Research Institute | 2017-12-15 |
| Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy? (NCT03269994) | Memorial Sloan Kettering Cancer Center | 2017-11-21 |
| Azacitidine and Pembrolizumab in Pancreatic Cancer (NCT03264404) | Susan E. Bates | 2017-10-01 |
| To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas (NCT03277209) | Weill Medical College of Cornell University | 2017-07-25 |
| Repeated EUS-guided Fine Needle Biopsy of Pancreatic Masses After Non-diagnostic or Inconclusive Results (NCT05226572) | University of Bologna | 2017-07-01 |
| RFA for Malignant Biliary Obstruction (NCT03166436) | Institute for Clinical and Experimental Medicine | 2017-06-08 |
| Endoscopic Ultrasound Guided Tissue Sampling (The SharkBITE Study) (NCT03532347) | Newcastle-upon-Tyne Hospitals NHS Trust | 2017-05-22 |
| Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor (NCT03093688) | Shanghai Public Health Clinical Center | 2017-03-01 |
| A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers (NCT03172572) | S (Sjors) Klompmaker, MD | 2017-02-01 |
| Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies (NCT02950025) | Washington University School of Medicine | 2017-01-19 |
| The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma (NCT06553040) | Ege University | 2017-01-01 |
| A Study to Determine Best Tumor Response With Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2 (HER2) Overexpressing Solid Tumors (NCT02999672) | Hoffmann-La Roche | 2016-12-23 |
| Establishment of Radiomics Database by Clinical Application of Multiparametric MRI Based on Incoherent Undersampling (NCT02944006) | Seoul National University Hospital | 2016-11-28 |
| Incidence of POPF in the Resection of the Left Pancreas With RFAT (NCT03570502) | Hospital del Mar | 2016-11-01 |
| Early Palliative Care in Patients With Metastatic Upper Gastrointestinal Cancers Treated With First-line Chemotherapy (NCT02853474) | Centre Oscar Lambret | 2016-10-01 |
| Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes (NCT02917798) | Memorial Sloan Kettering Cancer Center | 2016-07-12 |
| Epidural Analgesia Use in Pancreatic Resections (NCT02681796) | Washington University School of Medicine | 2016-06-07 |
| BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer (NCT02608229) | Washington University School of Medicine | 2016-06-06 |
| A Study of LY2880070 in Participants With Advanced or Metastatic Cancer (NCT02632448) | Esperas Pharma Inc. | 2016-05-16 |
| The Role of Muscle Cachexia in Pancreatic Cancer (NCT02515513) | University of Florida | 2016-03-01 |
| Radio Frequency Ablation in the Management of Pancreatico-biliary Disorders: A Multicenter Registry. (NCT04937322) | Methodist Health System | 2016-01-25 |
| Phase I of SGM-101 in Patients With Cancer of the Colon, Rectum or Pancreas (NCT02973672) | Surgimab | 2016-01-01 |
| International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) (NCT03210298) | Sabine Rhode | 2016-01-01 |
| Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma (NCT02352831) | Washington University School of Medicine | 2015-08-31 |
| Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer (NCT02311361) | National Cancer Institute (NCI) | 2015-03-25 |
| Intraoperative Radiation Therapy for Resectable Pancreas Cancer (NCT02599662) | Loyola University | 2015-01-01 |
| A New Scoring System for Perineural and Vascular Invasion in Pancreatic Cancer (NCT04024358) | Massimo Falconi | 2015-01-01 |
| Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients With Un-Resectable Pancreas Cancer (TL002) (NCT02707328) | The Cooper Health System | 2015-01-01 |
| Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy (NCT02307500) | Istituto Clinico Humanitas | 2014-12-01 |
| Radiofrequency Ablation for Biliopancreatic Malignancy (NCT02468076) | Universitaire Ziekenhuizen KU Leuven | 2014-11-01 |
| Outcomes of Surgical Resection of Pancreatic Cystic Neoplasms Based on the European Expert Consensus Statement: A Prospective Observational Study. (NCT04747600) | Zagazig University | 2014-06-01 |
| Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer (NCT01784081) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Pancreatic Cancer Early Detection Program (NCT02206360) | White Plains Hospital | 2014-04-01 |
| The Cancer of the Pancreas Screening-5 CAPS5)Study (NCT02000089) | Johns Hopkins University | 2014-01-06 |
| Pancreatic Cancer Recurrence in the Netherlands (NCT04605237) | UMC Utrecht | 2014-01-01 |
| Tumor Registry Pancreatic Cancer (NCT02089269) | iOMEDICO AG | 2013-12-01 |
| A Pilot, Prospective, Non-randomized Evaluation of the Safety of Anakinra Plus Standard Chemotherapy (NCT02021422) | Baylor Research Institute | 2013-12-01 |
| Maintenance Dovitinib for Colorectal and Pancreas Cancer (NCT01888965) | Georgetown University | 2013-10-01 |
| Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer (NCT01915225) | National Cancer Institute (NCI) | 2013-07-21 |
| Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. (NCT02078700) | Azienda USL Reggio Emilia - IRCCS | 2013-07-01 |
| Pancreas Registry and High Risk Registry (NCT02775461) | Icahn School of Medicine at Mount Sinai | 2013-03-01 |
| A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer (NCT02707315) | The Cooper Health System | 2013-01-01 |
| Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy (NCT06135649) | Universita di Verona | 2013-01-01 |
| Neoadjuvant FOLFIRINOX Regimen in Patients With Non-metastatic Pancrease Cancer (NCT01771146) | Baylor Research Institute | 2012-10-01 |
| Gemcitabine and CT-011 for Resected Pancreatic Cancer (NCT01313416) | Augusta University | 2012-09-01 |
| Quebec Pancreas Cancer Study (NCT04104230) | George Zogopoulos | 2012-03-12 |
| Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control (NCT02002806) | Indiana University | 2012-01-01 |
| The Role of Meat-borne Carcinogens in Pancreatic Cancer (NCT01092689) | University of Minnesota | 2012-01-01 |
| NEOadjuvant Gemcitabine/Oxaliplatin Plus Adjuvant Gemcitabine in Resectable PAncreatic Cancer (NCT01521702) | Institut Paoli-Calmettes | 2011-12-01 |
| Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer (NCT01446458) | Emory University | 2011-11-01 |
| Biomarker Directed Adjuvant Chemotherapy for Resected Pancreas Cancer (NCT01411072) | AHS Cancer Control Alberta | 2011-09-01 |
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas (NCT01231347) | NantCell, Inc. | 2011-04-07 |
| Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors (NCT01286987) | Pfizer | 2011-01-03 |
| Registry Study - Whipple at the Splenic Artery (NCT01155882) | Washington University School of Medicine | 2010-09-20 |
| Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV) (NCT01448668) | IFAG AG | 2010-09-01 |
| Lapatinib and Capecitabine for Second Line Treatment of Pancreas Cancer (NCT00881621) | Georgetown University | 2009-08-01 |
| DNA Microarray Study of Pancreas Cancer (NCT00680420) | Oregon Health and Science University | 2008-06-01 |
| Cancer Development In Organ Transplant Recipients (NCT02333279) | University of Zurich | 2008-05-01 |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (NCT00660205) | University of Aarhus | 2008-02-01 |
| Study of Pemetrexed for Second-Line Pancreas Cancer (NCT00864513) | Georgetown University | 2007-10-01 |
| Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy (NCT00809081) | Yonsei University | 2007-07-01 |
| Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint (NCT00613730) | Amgen | 2007-01-01 |
| Preoperative Stent Study (NCT00501176) | Karolinska Institutet | 2006-12-01 |
| Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail (NCT00500968) | Karolinska Institutet | 2006-11-01 |
| Reconstruction Following Pancreaticoduodenectomy: A Randomized Clinical Trial of Pancreaticojejunostomy vs Pancreaticogastomy (NCT00841607) | Tom Baker Cancer Centre | 2006-08-01 |
| Safety and Efficacy of the Therapeutic Vaccine GI-4000 in Combination With Gemcitabine Versus Placebo for the Treatment of Non-metastatic, Post-resection Pancreas Cancer (NCT00300950) | GlobeImmune | 2006-01-01 |
| Three New Methods for Diagnosing Pancreas Cancer (NCT00259532) | University of Copenhagen | 2005-02-01 |
| Preoperative Inflammatory Biomarkers and Postoperative Day 1 Drain Amylase Value Predict Pancreatic Fistula After Pancreaticoduodenectomy (NCT04361682) | Campus Bio-Medico University | 2005-01-01 |
| Pancreatic Cancer Serum and DNA Repository (NCT00296114) | Pancreatic Cancer Research Team | 2004-02-01 |
| Pancreaticoduodenectomy in Elderly Pancreatic Ductal Adenocarcinoma Patients (NCT03659903) | The First Affiliated Hospital of Dalian Medical University | 2004-01-01 |
| Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor (NCT01684098) | Endocyte | 2003-08-01 |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer (NCT01016639) | Lund University Hospital | 2003-06-01 |